Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Indraprastha Medical
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Indraprastha Medical

WEBSITE BSE:532150 NSE: INDRAPRAST Inc. Year: 1988 Industry: Hospital & Healthcare Services My Bucket: Add Stock

₹406.5 0 | 0%

Last updated: 15:53

Consolidated Standalone

Last updated: 15:53

Indraprastha Medical Overview

Indraprastha Medical Corporation Ltd is an India-based company, that is engaged in the healthcare business. The predominant enterprise of the Company is to provide comprehensive hospital services. It operates approximately 4000 pharmacies across India.

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Indraprastha Medical Key Financials

Market Cap ₹3726 Cr.

Stock P/E 23.1

P/B 5.3

Current Price ₹406.5

Book Value ₹ 76.3

Face Value 10

52W High ₹640.1

Dividend Yield 1.11%

52W Low ₹ 342.4

Edit Ratio

Indraprastha Medical Share Price

₹ | |

Volume
Price

Indraprastha Medical Quarterly Price

Quarterly Monthly
Show Value Show %

Indraprastha Medical Peer Comparison

Indraprastha Medical Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 317 306 315 348 350 325 334 365 381 372
Other Income 4 4 5 5 6 5 6 7 7 7
Total Income 321 311 320 353 356 330 340 372 388 379
Total Expenditure 267 259 266 281 286 273 272 292 310 310
Operating Profit 55 52 53 72 70 57 68 80 79 69
Interest 1 1 2 2 2 2 1 2 2 1
Depreciation 10 10 10 11 11 11 11 10 11 11
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 44 41 42 60 57 45 55 68 66 56
Provision for Tax 11 11 10 15 15 12 14 17 17 15
Profit After Tax 33 29 31 45 42 33 41 51 49 41
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 33 29 31 45 42 33 41 51 49 41
Adjusted Earnings Per Share 3.6 3.2 3.4 4.9 4.6 3.6 4.5 5.6 5.4 4.5

Indraprastha Medical Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 714 755 766 753 788 831 613 888 1099 1245 1356 1452
Other Income 1 2 0 1 0 1 1 3 10 17 23 27
Total Income 715 758 766 753 789 831 614 891 1109 1262 1379 1479
Total Expenditure 630 676 687 680 707 744 573 774 948 1051 1112 1184
Operating Profit 86 81 79 74 81 87 41 117 161 210 267 296
Interest 8 7 8 9 7 6 3 3 4 4 6 6
Depreciation 28 35 31 31 30 33 33 35 39 40 44 43
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 50 39 41 34 45 48 4 79 117 166 216 245
Provision for Tax 17 14 15 13 16 5 2 20 31 42 55 63
Profit After Tax 32 24 26 21 28 44 2 59 86 124 161 182
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 32 24 26 21 28 44 2 59 86 124 161 182
Adjusted Earnings Per Share 3.5 2.7 2.9 2.3 3.1 4.8 0.3 6.4 9.4 13.5 17.6 20

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 9% 15% 10% 7%
Operating Profit CAGR 27% 32% 25% 12%
PAT CAGR 30% 40% 30% 18%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -3% 68% 46% 22%
ROE Average 30% 28% 21% 17%
ROCE Average 41% 39% 29% 23%

Indraprastha Medical Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 195 224 231 232 244 268 273 325 379 478 597
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 11 2 0 21 15 0 0 0 0 0 0
Other Non-Current Liabilities 42 44 42 41 39 42 43 43 46 80 76
Total Current Liabilities 194 191 186 138 124 140 116 94 130 165 179
Total Liabilities 442 460 458 432 422 449 432 462 555 723 852
Fixed Assets 286 301 296 294 280 303 283 277 275 347 328
Other Non-Current Assets 7 7 5 5 7 5 7 26 57 68 92
Total Current Assets 149 152 158 133 136 141 141 159 223 308 431
Total Assets 442 460 458 432 422 449 432 462 555 723 852

Indraprastha Medical Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 3 2 2 3 17 20 25 42 52 62
Cash Flow from Operating Activities 64 62 28 48 75 86 27 94 144 200 157
Cash Flow from Investing Activities -29 -33 -22 -30 -17 -40 -19 -74 -108 -158 -111
Cash Flow from Financing Activities -35 -30 -5 -17 -44 -43 -3 -3 -26 -32 -46
Net Cash Inflow / Outflow -0 -0 -0 1 14 4 5 17 11 9 -0
Closing Cash & Cash Equivalent 2 2 2 3 17 20 25 42 52 62 61

Indraprastha Medical Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.54 2.67 2.86 2.3 3.1 4.76 0.25 6.39 9.4 13.52 17.56
CEPS(Rs) 6.62 6.52 6.19 5.65 6.35 8.36 3.89 10.21 13.68 17.89 22.4
DPS(Rs) 1.8 1.8 1.8 1.5 1.6 0 0 2.5 3 4.5 4.5
Book NAV/Share(Rs) 21.25 24.41 25.18 25.34 26.62 29.21 29.75 35.5 41.39 52.12 65.09
Core EBITDA Margin(%) 11.88 10.51 10.29 9.67 10.25 10.4 6.57 12.87 13.72 15.53 18.01
EBIT Margin(%) 8.07 6.11 6.36 5.7 6.53 6.51 1.24 9.29 11.06 13.67 16.41
Pre Tax Margin(%) 6.94 5.13 5.33 4.52 5.66 5.8 0.7 8.9 10.67 13.35 15.95
PAT Margin (%) 4.55 3.23 3.43 2.8 3.6 5.25 0.38 6.6 7.84 9.96 11.87
Cash Profit Margin (%) 8.49 7.91 7.41 6.88 7.38 9.22 5.81 10.53 11.42 13.18 15.14
ROA(%) 7.3 5.42 5.71 4.74 6.65 10.01 0.53 13.12 16.94 19.39 20.45
ROE(%) 17.02 11.68 11.55 9.11 11.93 17.05 0.86 19.6 24.44 28.92 29.97
ROCE(%) 23.29 17.72 16.98 14.4 18.29 20.15 2.8 27.58 34.46 39.7 41.43
Receivable days 36.3 39.26 43.64 44.32 37.2 34.13 43.6 22.76 18.54 18.57 18.01
Inventory Days 6.35 5.32 4.65 4.62 4.04 4.48 6.19 3.85 3.06 2.34 1.95
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 15.69 19.49 18.53 20.98 12.37 7.13 211.45 9.14 8.27 12.7 21.98
Price/Book(x) 2.62 2.13 2.11 1.91 1.44 1.16 1.81 1.65 1.88 3.3 5.93
Dividend Yield(%) 3.24 3.46 3.39 3.11 4.17 0 0 4.28 3.86 2.62 1.17
EV/Net Sales(x) 0.78 0.69 0.71 0.66 0.44 0.35 0.76 0.53 0.53 1.08 2.37
EV/Core EBITDA(x) 6.45 6.41 6.9 6.8 4.31 3.34 11.36 3.98 3.63 6.42 12.05
Net Sales Growth(%) 5.44 5.74 1.36 -1.71 4.72 5.4 -26.17 44.8 23.7 13.29 8.97
EBIT Growth(%) -9.5 -19.92 5.53 -11.94 20.02 5.08 -85.9 981 47.26 40.1 30.8
PAT Growth(%) -8.31 -24.8 7.42 -19.59 34.64 53.54 -94.66 2415.88 46.96 43.89 29.87
EPS Growth(%) -8.31 -24.8 7.42 -19.59 34.64 53.54 -94.66 2415.62 46.96 43.89 29.87
Debt/Equity(x) 0.26 0.23 0.29 0.28 0.09 0.01 0 0 0 0 0
Current Ratio(x) 0.77 0.8 0.85 0.96 1.09 1.01 1.22 1.7 1.72 1.86 2.41
Quick Ratio(x) 0.7 0.75 0.8 0.89 1.03 0.93 1.14 1.59 1.66 1.82 2.37
Interest Cover(x) 7.11 6.22 6.16 4.82 7.49 9.14 2.28 24.19 28.38 41.91 35.5
Total Debt/Mcap(x) 0.1 0.11 0.14 0.15 0.06 0.01 0 0 0 0 0

Indraprastha Medical Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 51 51 51 51 51 51 51 51 51 51
FII 0.95 1.08 1.7 2.64 2.88 2.94 2.72 2.41 2.73 2.44
DII 6.37 4.91 3.15 3.2 3.19 3.56 3.56 3.51 0.83 0.87
Public 41.68 43.01 44.15 43.16 42.93 42.51 42.72 43.08 45.44 45.69
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Indraprastha Medical News

Indraprastha Medical Pros & Cons

Pros

  • Company has delivered good profit growth of 29% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28%
  • Company is almost debt free.

Cons

  • Stock is trading at 5.3 times its book value.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!